Drug Treatment of Duchenne Muscular Dystrophy (DMD): Current Therapies, Gene Therapy Advances, and Future Trends
In 1852, French physician Duchenne described boys with progressive muscle weakness whose enlarged calves were…
News
Why Reputable Pharmaceutical Wholesaler is the Key to Long-Term Partnership Success？
In today’s increasingly competitive global pharmaceutical landscape, choosing a reputable pharmaceutical wholesaler has become a…
Complete Lung Cancer Drugs List (2026 Update)
Lung cancer remains the leading cause of cancer death worldwide, with non-small cell lung cancer…
ALK Inhibitors for Lung Cancer: Generational Evolution and Impact on Clinical Practice
Before the advent of targeted therapy, ALK-positive advanced non-small cell lung cancer (NSCLC) typically progressed…
From First- to Third-Generation EGFR-targeted Drugs: How Can Patients Understand Differences in Efficacy and Adverse Effects?
Epidermal growth factor receptor EGFR–targeted drugs represent a cornerstone in the treatment of advanced non–small…
What Is Qipani Olaparib Used For? China Approves First Domestic Olaparib Generic, Marking a New Milestone in PARP Inhibitor Access
In May 2023, China’s National Medical Products Administration (NMPA) approved the first domestically developed generic…
Top 5 Global Rare Disease Companies: An In-Depth Analysis of Roche, Novartis, Johnson & Johnson, AstraZeneca, and Vertex
In recent years, rare disease treatment has rapidly risen from a niche medical issue to…
What Class of Drug Is Penpulimab? How This Fc-Engineered PD-1 Monoclonal Antibody Restores Anti-Tumor Immunity?
In recent years, immune checkpoint inhibitors have revolutionized the field of anti-tumor treatment, among which…
Abbisko’s Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor: China’s First Class-1 CSF-1R Inhibitor Approved for TGCT
In the field of tenosynovial giant cell tumor (TGCT), a rare but persistent disease that…
What Is Ponatinib Used For? Targeting T315I-Mutant CML and Ph+ ALL
In the treatment of leukemia, not all patients respond equally to standard therapies. Drug resistance…
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights